Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, and aspirin could be effective in reducing the risk of Alzheimer's disease, a new study suggests.

A report published in the medical journal of the American Academy of Neurology presented findings taken from the collated data of six different studies investigating the benefits of NSAIDs in relation to the development of dementia.

Neurologists found that patients who used NSAIDs had 23 per cent lower risk of developing Alzheimer's disease compared to those who never used NSAIDs.

Study author Dr Peter P Zandi, from Johns Hopkins Bloomberg School of Public Health in Baltimore, commented: "The NSAID group that includes ibuprofen was thought to target a certain type of plaque in the brain found in Alzheimer's patients."

Experts have previously debated whether a certain group of NSAIDs that includes ibuprofen may be more beneficial than another group that includes naproxen and aspirin.

However, the latest findings showed that the risk reduction of developing Alzheimer's was not dependent on the type of NSAID taken.

According to non-profit organisation Alzheimer's Europe, between 50 and 70 per cent of patients with dementia are suffering from Alzheimer's disease.

Login and visit the Alzheimer's Disease Knowledge Centre

• Study describes changes in key Alzheimer's protein in humans 29/08/08
• Rat brain controlled robot could help in Alzheimer's research, scientists state 21/08/08
• Compounds have potential for Alzheimer's treatment, study suggests 21/08/08
• New drug offers hope to Alzheimer's sufferers 30/07/08
• Statins linked to reduced dementia risk 29/07/08